Genmab — Januar 2018
-
"Novo Nordisk koncernfinansdirektør, Jesper Brandgaard, siger mandag morgen på en telekonference, at medicinalkoncernen er klar til at ændre sit købstilbud, hvis forhandlinger med bestyrelsen i Ablynx afslører, at der er mere værdi i det belgiske biotekselskab"
-
Tror ikke de har givet op endnu, men det ser ikke i skrivende stund ud til at de kan presse prisen ned, da der er fint med købere
-
AB har i hvert fald smidt 13.5k aktier her den første time
-
-
Jeg brugte den her, der er opdateret i oktober...https://www.finanstilsynet.dk/da/Lovgivning/Information-om-udvalgte-tilsynsomraader/Short-selling/Offentliggjorte-positioner
-
I was asked to give my opinion so here it is: bit.ly/davidmygind
-
-
Feel free to share with others if you find it interesting..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind